Antibody–Drug Conjugates Emerge as Immune Modulators, Not Just Targeted Chemotherapy
A new review argues that antibody–drug conjugates act as immune modulators through immunogenic cell death, Fc-mediated effector functions and tumour ...
A new review argues that antibody–drug conjugates act as immune modulators through immunogenic cell death, Fc-mediated effector functions and tumour ...
A Taiwanese preliminary study found that following a short course of immune checkpoint inhibitors with infusions of tumor-primed dendritic cells ...
A new analysis suggests HIV impairs the immune system's ability to recognize tumor neoantigens in non-small cell lung cancer without ...
A genomic study of 841 melanoma patients at NYU Langone Health found that underrepresented minority patients experienced significantly more immune ...
A new review synthesizes clinical trial evidence showing that combining radiotherapy with immune checkpoint inhibitors can dramatically boost response rates ...
A new framework in the Journal of Translational Medicine defines when blood-cell clones should be treated as sequencing artifacts, host ...
A 2023 review from Fudan University documents how Chinese clinical trials and single-cell omics studies are transforming the treatment and ...
In a groundbreaking study, researchers have unveiled a significant case of pure red cell aplasia induced by immune checkpoint inhibitors, ...
In a groundbreaking study soon to be published, researchers have unveiled a vital connection between salivary microbial signatures and the ...
Chimeric Antigen Receptor (CAR) T cell therapies have heralded a new era in oncological treatment, yielding transformative outcomes particularly in ...
In the field of cancer research, the complexities of immunology and metabolism present a fascinating but daunting landscape. Recent findings ...
In a breakthrough study that may revolutionize cancer treatment paradigms, researchers at Cincinnati Children’s have uncovered a critical genetic mutation ...
In the relentless battle against cancer, immunotherapy has emerged as a beacon of hope, revolutionizing treatment paradigms with its ingenious ...
Immunotherapy has emerged as a pivotal area of research in the global fight against tuberculosis (TB), a disease that has ...
In a landmark discovery that could alter the course of cancer treatment, researchers at The University of Texas MD Anderson ...
In a groundbreaking phase Ib clinical trial published in BMC Cancer, researchers have unveiled promising results exploring the combination of ...
In a groundbreaking real-world study published in BMC Cancer, researchers have unveiled compelling evidence supporting the survival benefits of combining ...
The Intricacies and Therapeutic Promise of Mismatch Repair-Deficient Cancers In the ever-evolving landscape of cancer biology, one molecular pathway has ...
In recent years, the intricate relationship between DNA repair mechanisms and cancer development has come into sharper focus, spotlighting a ...
A groundbreaking editorial recently published in the latest volume of Oncoscience sheds new light on the complex relationship between immune ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.